SP Tulsian positive on Biocon, Aurobindo Pharma, Divis Lab and Sun Pharma

Stock market guru, SP Tulsian, on Friday said he continued to maintain positive view on Biocon, Aurobindo Pharma, Divis Lab and Sun Pharma.

Tulsian said state-owned Oil India Ltd is always been a laggard, "The company is just one tenth of ONGC in terms of turnover, production, volume and profitability ballpark."

"If ONGC corrects by 3-4 percent, Oil India has to take a hit by about 5-6 percent as profitability impact would be higher in case of Oil India than ONGC. Upstream companies will be having the negative bias because of crude softness," Tulsian said.